What question did this study set out to answer?

This research aims to explore the prognostic impact of cxcr4 mutation types in waldenström macroglobulinemia on clinical features and patient outcomes.

December 8, 2025BloodOpen Access

Prognostic impact of CXCR4 mutation type on clinical features and outcomes of patients with Waldenström macroglobulinemia

View Full Paper

Ask AI

Bookmark

Authors

LGLorenzo Gensini WDWenli Dong MGMahmoud R. Gaballa

Discussion

Member takes

Overview

Retrospective analysis shows no survival difference by cxcr4 mutation status in waldenström macroglobulinemia patients, suggesting broader implications for treatment strategies.

Key Points

This research aims to explore the prognostic impact of cxcr4 mutation types in waldenström macroglobulinemia on clinical features and patient outcomes.
Conducted a single-center retrospective analysis of patients with waldenström macroglobulinemia or igm mgus
Included patients with cxcr4 mutation testing via next-generation sequencing
Analyzed overall survival using log-rank tests based on mutation status and type.
34% of patients had cxcr4 mutations
No significant differences in overall survival based on cxcr4 mutation status
Nonsense mutations and other cxcr4 mutation types did not alter survival rates in the study cohort.

Cite This Study

Gensini et al. (2025) studied this question.

synapsesocial.com/papers/69362f3a4fa91c937236d471 https://doi.org/10.1182/blood-2025-1829

View Full Paper

Ask AI

Bookmark

December 8, 2025BloodOpen Access

Prognostic impact of CXCR4 mutation type on clinical features and outcomes of patients with Waldenström macroglobulinemia

View Full Paper

Ask AI

Bookmark

Authors

LGLorenzo Gensini WDWenli Dong MGMahmoud R. Gaballa

Discussion

Member takes

Overview

Retrospective analysis shows no survival difference by cxcr4 mutation status in waldenström macroglobulinemia patients, suggesting broader implications for treatment strategies.

Key Points

This research aims to explore the prognostic impact of cxcr4 mutation types in waldenström macroglobulinemia on clinical features and patient outcomes.
Conducted a single-center retrospective analysis of patients with waldenström macroglobulinemia or igm mgus
Included patients with cxcr4 mutation testing via next-generation sequencing
Analyzed overall survival using log-rank tests based on mutation status and type.
34% of patients had cxcr4 mutations
No significant differences in overall survival based on cxcr4 mutation status
Nonsense mutations and other cxcr4 mutation types did not alter survival rates in the study cohort.

Cite This Study

Gensini et al. (2025) studied this question.

synapsesocial.com/papers/69362f3a4fa91c937236d471 https://doi.org/10.1182/blood-2025-1829

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark